3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
23
Fatigue
17
Neoplasms
9
Depression
6
Pain
5
Colorectal Neoplasms
4
Vomiting
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Nausea
3
Lung Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Anxiety Disorders
3
Sleep Wake Disorders
2
Sleep Initiation and Maintenance Disorders
2
Rectal Neoplasms
2
Polycystic Ovary Syndrome
2
Parasomnias
2
Oligodendroglioma
2
Obesity
2
Motor Activity
2
Meningioma
2
Medulloblastoma
2
Lymphedema
2
Leukemia
2
Head and Neck Neoplasms
2
Gliosarcoma
2
Glioblastoma
2
Interventions
Pregabalin
5
Lidocaine
4
Bupivacaine
3
ziconotide
2
Transcranial Magnetic Stimulation
2
Gabapentin
2
Capsaicin
2
Amitriptyline
2
onabotulinum toxin A
1
Yoga
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Thalidomide
1
Telmisartan
1
Surveys and Questionnaires
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Saline Solution
1
Radiofrequency Ablation
1
Paclitaxel
1
Oxycodone
1
Oxaliplatin
1
Manipulation, Osteopathic
1
Low-Level Light Therapy
1
Lidoderm
1
Ketamine
1
KRN 5500
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Neuralgia
×
Yoga
×
Clear all
NCT05121558
2026-02-06
YCT
Dana-Farber Cancer Institute
Phase NA
Active not recruiting
227 enrolled